cystic fibrosis – media

Implementation of Machine Learning to Foresee Need of Lung Transplants in CF Patients

Machine learning can forecast whether a cystic fibrosis (CF) patient should be sent for a lung transplant with a 35% enhancement in accuracy over current methods. These were the results of collaborated research done between Oxford University’s Alan Turing Institute and the Cystic Fibrosis Trust.
- Source: The Verdict
- 696
- August 6, 2018
cystic fibrosis digital health Researches
Toothpaste Combats Lung Disease

Cystic fibrosis is the most common lung affecting genetic disease, which often turns out to be life-threatening. Nearly one in every 2500 to 3500 people are diagnosed with cystic fibrosis at an early age. A thick mucus formation in the lungs becomes stuck to bacteria, which leads to a slimy biofilm formation.
- Source: India Times
- 514
- June 21, 2018
cystic fibrosis Researches
IPO Filed by Translate for Undertaking Fibrosis Treatment Trial

An IPO for raising USD 115 million from public investors has been filed by Translate Bio. Proceeds garnered from the IPO will be used by Translate to trial an mRNA candidate designed to allow cystic fibrosis patients produce CTFR proteins.
- Source: Ddu
- 587
- June 6, 2018
Clinical Trials cystic fibrosis
FDA Approves SYMDEKOTM (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older with Certain Mutations in the CFTR Gene

Vertex Pharmaceuticals Incorporated (VRTX) today announced that the U.S. Food and Drug Administration (FDA) approved SYMDEKO™ (tezacaftor/ivacaftor and ivacaftor) for treating the underlying cause of cystic fibrosis (CF) in people ages 12 and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or who have at least one mutation that is responsive to tezacaftor/ivacaftor. SYMDEKO is Vertex’s third medicine approved to treat the underlying cause of CF. Vertex is ready to launch SYMDEKO and will begin shipping it to pharmacies in the United States this week.
- Source: finance.yahoo.
- 569
- March 1, 2018
cystic fibrosis FDA New Approvals SYMDEKO™

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.